| Literature DB >> 25413326 |
Min Chul Lee1, Randeep Rakwal2, Junko Shibato3, Koshiro Inoue4, Hyukki Chang5, Hideaki Soya4.
Abstract
In two separate experiments, voluntary resistance wheel running with 30% of body weight (RWR), rather than wheel running (WR), led to greater enhancements, including adult hippocampal neurogenesis and cognitive functions, in conjunction with hippocampal brain-derived neurotrophic factor (BDNF) signaling (Lee et al., J Appl Physiol, 2012; Neurosci Lett., 2013). Here we aimed to unravel novel molecular factors and gain insight into underlying molecular mechanisms for RWR-enhanced hippocampal functions; a high-throughput whole-genome DNA microarray approach was applied to rats performing voluntary running for 4 weeks. RWR rats showed a significant decrease in average running distances although average work levels increased immensely, by about 11-fold compared to WR, resulting in muscular adaptation for the fast-twitch plantaris muscle. Global transcriptome profiling analysis identified 128 (sedentary × WR) and 169 (sedentary × RWR) up-regulated (>1.5-fold change), and 97 (sedentary × WR) and 468 (sedentary × RWR) down-regulated (<0.75-fold change) genes. Functional categorization using both pathway- or specific-disease-state-focused gene classifications and Ingenuity Pathway Analysis (IPA) revealed expression pattern changes in the major categories of disease and disorders, molecular functions, and physiological system development and function. Genes specifically regulated with RWR include the newly identified factors of NFATc1, AVPR1A, and FGFR4, as well as previously known factors, BDNF and CREB mRNA. Interestingly, RWR down-regulated multiple inflammatory cytokines (IL1B, IL2RA, and TNF) and chemokines (CXCL1, CXCL10, CCL2, and CCR4) with the SYCP3, PRL genes, which are potentially involved in regulating hippocampal neuroplastic changes. These results provide understanding of the voluntary-RWR-related hippocampal transcriptome, which will open a window to the underlying mechanisms of the positive effects of exercise, with therapeutic value for enhancing hippocampal functions.Entities:
Keywords: DNA microarray; hippocampus; inflammatory cytokine; resistance wheel running
Year: 2014 PMID: 25413326 PMCID: PMC4255813 DOI: 10.14814/phy2.12206
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1.Workflow from sampling and grinding of the hippocampus, total RNA extraction, and DNA microarray analysis of the hippocampus. (A) The rats hippocampi were rapidly dissected and ground to a fine powder in liquid nitrogen and stored at –80°C. (B) Total RNA extraction from the finely powdered hippocampus. Total RNA quality was confirmed by both spectrophotometry and agarose‐gel electrophoresis. (C) DNA microarray chip showing the hybridized sample combinations (Sed × WR and Sed × RWR) and dye‐swap (Cy3 vs. Cy5).
The list of primers used for real‐time PCR
| Primer name | Direction | Sequence | NCBI accession no. |
|---|---|---|---|
| IL1b | Forward | 5′‐ attgtggctgtggagaagct ‐3′ | NM‐031512 |
| Reverse | 5′‐ atgtcccgaccattgctgtt ‐3′ | ||
| IL2ra | Forward | 5′‐ gcaacaactgtcagtgcaca ‐3′ | NM‐013163 |
| Reverse | 5′‐ tatgttgccaggtgaaccca ‐3′ | ||
| TNF | Forward | 5′‐ gtgcctcagcctcttctcatt ‐3′ | NM‐012675 |
| Reverse | 5′‐ tcccaggtacatgggctcata ‐3′ | ||
| Cxcl1 | Forward | 5′‐ acagtggcagggattcactt ‐3′ | NM‐030845 |
| Reverse | 5′‐ tcgcgaccattcttgagtgt ‐3′ | ||
| Cxcl10 | Forward | 5′‐ atgaacccaagtgctgctgt ‐3′ | NM‐139089 |
| Reverse | 5′‐ tctttggctcaccgctttca ‐3′ | ||
| Ccl2 | Forward | 5′‐ aggtgtcccaaagaagctgt ‐3′ | NM‐031530 |
| Reverse | 5′‐ tgcttgaggtggttgtggaa ‐3′ | ||
| NFATc1 | Forward | 5′‐ tgtcgtgcagctacatggtt ‐3′ | NM‐001244933 |
| Reverse | 5′‐ tcggtcagttttcgcttcca ‐3′ | ||
| AVPr1a | Forward | 5′‐ tttttgtggtggctgtgctg ‐3′ | BC‐088095 |
| Reverse | 5′‐ atgttgcgccagatgtggta ‐3′ | ||
| BDNF | Forward | 5′‐ gcggcagataaaaagactgc ‐3′ | NM‐012513 |
| Reverse | 5′‐ gccagccaattctctttttg‐3′ | ||
| TrkB | Forward | 5′‐ gacctgatcctgacgggtaa ‐3′ | NM‐001163169 |
| Reverse | 5′‐ tggtcacagacttcccttcc ‐3′ | ||
| CREB | Forward | 5′‐ tcagccgggtactaccattc‐3′ | X14788 |
| Reverse | 5′‐ cctctctctttcgtgctgct ‐3′ | ||
| β‐Actin | Forward | 5′‐ aaccctaaggccaaccgtga‐3′ | NM‐031144 |
| Reverse | 5′‐ cagggacaacacagcctgga ‐3′ |
Effects of resistance wheel running (RWR) on body weight, exercise parameters, muscle adaptation, and stress‐related factors
| Group | |||
|---|---|---|---|
| Sedentary | WR | RWR | |
| Body weight (g) | 510.4 ± 8.4 | 457.6 ± 8.3** | 462.5 ± 10.2* |
| Exercise parameters | |||
| Average daily running distance (m) | 1031.5 ± 42.2 | 683.2 ± 105.4* | |
| Average daily work levels (N m/kg b.w./day) | 112.1 ± 3.6 | 1247.9 ± 198.4*** | |
| Muscle adaptation | |||
| Relative soleus wet mass to b.w. (mg/100 g) | 45.2 ± 1.3 | 48.8 ± 1.5 | 50.5 ± 1.5* |
| Relative plantaris wet mass to b.w. (mg/100 g) | 92.9 ± 1.6 | 101.5 ± 1.6 | 106.3 ± 3.9* |
| Stress‐related factors | |||
| Relative adrenals Wt to b.w. (mg/100 g) | 13.4 ± 0.5 | 14.2 ± 0.8 | 12.3 ± 0.8 |
| Relative thymus Wt to b.w. (mg/100 g) | 91.5 ± 5.6 | 105.1 ± 6.8 | 106.1 ± 4.9 |
All data are presented as the mean ± SE. BW, body weight; CS, citrate synthase; Wt, weight; Sed, sedentary; WR, wheel running with no resistance; RWR, resistance wheel running. Significant difference compared with sedentary after an ANOVA with Tukey's multiple comparison tests or Student's t‐test: *P <0.05; ***P <0.001.
Figure 2.Differentially expressed genes in the WR and RWR. The numbers above each bar indicate the selection of genes from the total microarray datasets within a defined fold range of greater than 1.5‐fold and less than 0.75‐fold.
Figure 3.Biological pathway and gene classification. The up‐ and down‐regulated genes at Sed × WR and Sed × RWR were classified based on the available categories of more than 100 biological pathways and gene classification in the SABiosciences PCR array list. The numbers in the y‐axis represent number of genes in each category, which are indicated on the x‐axis.
The 10 hippocampal transcripts induced and 10 most repressed with resistance wheel running (RWR)
| Symbol | Gene name | Agilent | Fold change | Location | Type(s) |
|---|---|---|---|---|---|
| Up‐regulated molecules | |||||
| NYX | Nyctalopin | A_44_P283938 | 3.000 | Extracellular Space | Other |
| Cyp2c40 (includes others) | Cytochrome P450, family 2, subfamily c, polypeptide 40 | A_44_P302721 | 2.830 | Cytoplasm | Enzyme |
| PGK2 | Phosphoglycerate kinase 2 | A_44_P263049 | 2.760 | Cytoplasm | Kinase |
| CDC6 | Cell division cycle 6 homolog ( | A_44_P239281 | 2.440 | Nucleus | Other |
| Cyp2b19 | Cytochrome P450, family 2, subfamily b, polypeptide 19 | A_44_P482563 | 2.140 | Cytoplasm | Enzyme |
| FGFR4 | Fibroblast growth factor receptor 4 | A_44_P546866 | 2.090 | Plasma Membrane | Kinase |
| Olfr1436/Olfr1437 | Olfactory receptor 1437 | A_44_P233666 | 2.090 | Plasma Membrane | G‐protein‐coupled receptor |
| ANXA8L2 (includes others) | Annexin A8‐like 2 | A_44_P525229 | 2.060 | Plasma Membrane | Other |
| NCF2 | Neutrophil cytosolic factor 2 | A_44_P508554 | 2.060 | Cytoplasm | Enzyme |
| CCKAR | Cholecystokinin A receptor | A_43_P15402 | 2.040 | Plasma Membrane | G‐protein‐coupled receptor |
| Down‐regulated Molecules | |||||
| CXCL1 | Chemokine (C‐X‐C motif) ligand 1 | A_42_P473398 | −4.348 | Extracellular Space | Cytokine |
| PRL | Prolactin | A_43_P11492 | −4.000 | Extracellular Space | Cytokine |
| CXCL9 | Chemokine (C‐X‐C motif) ligand 9 | A_44_P1043157 | −3.333 | Extracellular Space | Cytokine |
| PDK4 | Pyruvate dehydrogenase kinase, isozyme 4 | A_44_P812772 | −3.226 | Cytoplasm | Kinase |
| CCL13 | Chemokine (C‐C motif) ligand 13 | A_42_P695401 | −3.226 | Extracellular Space | Cytokine |
| DOCK8 | Dedicator of cytokinesis 8 | A_44_P944006 | −3.125 | Cytoplasm | Other |
| OR6C1 | Olfactory receptor, family 6, subfamily C, member 1 | A_44_P974878 | −3.030 | Plasma Membrane | G‐protein‐coupled receptor |
| IL10 | Interleukin 10 | A_44_P384213 | −3.030 | Extracellular Space | Cytokine |
| ATP7B | ATPase, Cu++ transporting, beta polypeptide | A_44_P306339 | −3.030 | Cytoplasm | Transporter |
| TRPM1 | Transient receptor potential cation channel, subfamily M, member 1 | A_44_P295064 | −2.941 | Plasma Membrane | Ion channel |
Functional gene groupings sensitive to voluntary resistance wheel running (RWR)
| Category | Number of genes | |
|---|---|---|
| Diseases and Disorders | ||
| Immunological Disease | 2.61E‐07–3.46E‐03 | 39 |
| Hypersensitivity Response | 7.24E‐07–1.38E‐03 | 19 |
| Inflammatory Response | 2.28E‐06–3.89E‐03 | 49 |
| Cardiovascular Disease | 3.25E‐06–2.44E‐03 | 59 |
| Infectious Disease | 4.87E‐06–3.12E‐03 | 31 |
| Molecular and Cellular Functions | ||
| Protein Synthesis | 8.75E‐09–3.60E‐03 | 26 |
| Cellular Movement | 3.78E‐07–3.78E‐03 | 41 |
| Cell‐To‐Cell Signaling and Interaction | 1.61E‐06–3.89E‐03 | 50 |
| Cell Signaling | 7.76E‐06–2.67E‐03 | 38 |
| Small Molecule Biochemistry | 7.76E‐06–3.60E‐03 | 40 |
| Physiological System Development and Function | ||
| Nervous System Development and Function | 3.93E‐11–3.00E‐03 | 73 |
| Humoral Immune Response | 8.75E‐09–3.46E‐03 | 24 |
| Cell‐mediated Immune Response | 3.78E‐07–3.88E‐03 | 24 |
| Hematological System Development and Function | 3.78E‐07–3.89E‐03 | 68 |
| Immune Cell Trafficking | 3.78E‐07–3.89E‐03 | 46 |
Functional groupings of transcripts differentially modified by RWR (also shown are P‐values, and numbers of involved genes). The groups derived from Ingenuity Pathway Analysis (IPA) are categorized into disease and disorders, molecular functions, and physiological system development and function.
The top five gene networks modified with wheel running (WR) and resistance wheel running (RWR)
| Network | Associated network functions | Score | Focus molecules | Molecules in network |
|---|---|---|---|---|
| Sedentary × WR | ||||
| 1 | Amino Acid Metabolism, Endocrine System Development and Function, Molecular Transport | 30 | 15 | ADIPOQ,B4GALT1,beta‐stradiol,CCL13,CD69,CXCL10,DOCK8,DRD2,GCNT4,GHR,IFNG,IgG1,IgG,IgG2a,Igm,IL4,IL5,IL10,IL13,LEP,levothyroxine,Mbl1,Na+,NOS2, PDCD1LG2,PRL,PRLR,RSAD2,SCNN1G,THRA,THRB,TNF,TRH,TTR2 |
| 2 | Protein Synthesis, Gene Expression, Cellular Movement | 11 | 7 | ADIPOQ,blood urea nitrogen,caspase,CCL13,chemokine,CNPY3,CORO1B,CYP19A1,D‐glucose,dopamine,ESR2,HSPA1A/HSPA1B,IFNB1,IFNG,IGF1,IgG2a,IL4,IL6,IL10,IL12 (family),IL12B,IL1B,Ins1,LEP,NLRC3,PARG,PCK1,PGLYRP4,SMAD3,TNF,TNFRSF10A,TOLLIP,Trim30a/Trim30d,VIL1 |
| 3 | Cellular Movement | 2 | 1 | Mapk, PIK3R6 |
| 4 | Cell Morphology, Connective Tissue Development and Function, Embryonic Development | 2 | 1 | GPR55,PLC |
| 5 | Drug Metabolism, Lipid Metabolism, Molecular Transport | 2 | 1 | ADH1C,ethanol |
| Sedentary × RWR | ||||
| 1 | Humoral Immune Response, Protein Synthesis, Cellular Movement | 44 | 24 | AVPR1A,C5,CCL13,CCR4,CD81,chemokine,CXCL9,CXCL10,DOCK8,FGG,GALNT1, HMOX1,ICOS,Iga,Ige,IgG1,Igg3,IgG,IgG2a,IgG2b,Igm,IL10,IL1B,IL2RA, LDL‐cholesterol,MAN2A1,MEP1A,NAIP,NFATC1,NOS2,SDC1,SOAT2,TNF,TRB@, VLDL‐cholesterol |
| 2 | Cellular Movement, Immune Cell Trafficking, Humoral Immune Response | 23 | 15 | CCL13,CCR4,CCR6,CD69,CD80,DAPP1,EFEMP1,EPO,FGFR4,FLT4,GATA3,GNAI2, GPR34,GPT,hemoglobin,HIF1A,IFNG,Igm,IL5,ITGA5,L‐tyrosine,LAMA4,LTA,MMP9, NOS2,PTGER4,RARA,RSAD2,SELL,SELP,TBX21,TNFRSF14,TNFRSF21,TNFSF13, ZC3H12A |
| 3 | Protein Synthesis, Endocrine System Development and Function, Molecular Transport | 17 | 12 | ABCA1,ADCYAP1,ALB,APOE,beta‐estradiol,CACNA1C,CCKAR,CD36,CGA, CYP19A1,DRD2,ESR1,FSH,GABBR1,GCG,GHR,GPR119,HDL‐cholesterol, Immunoglobulin,Insulin,IRS1,IRS2,LATS1,Lh,NOS2,PGR,PRL,PRLR,progesterone, SST,SYT9,testosterone,THRA,THRB |
| 4 | Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry | 17 | 12 | AIM2,AMELX,CCL13,CKM,Collagen(s),D‐glucose,ERC1,glycogen,H6PD, IHH,IKBKG,Ins1,IRAK2,IRAK3,IRS2,IRS4,NFkB (complex),NFKBIB,NOD1, PARG,PDK4,PGR,RHEBL1,RIPK1,RIPK2,RPS6KA4,RPS6KA5, SLC5A1,TGFB1,THRA,TNF,TNFRSF8,TNFSF14,TRAF2,UCP3 |
| 5 | Cell Death and Survival, Cancer, Hematological Disease | 10 | 5 | BCL2L1, caspase,COL4A3,FASLG,PML,TNFAIP8 |
The “Score” reflects the negative log of the P value and signifies the likelihood of network‐eligible genes within a network being clustered together as a result of chance. See (Figs. 4, 5) for details of networks 1 and 2.
Figure 4.The two top gene networks sensitive to free wheel running. Ingenuity Pathway Analysis software was used to identify the most significantly modified gene networks from Sed × WR. (A) Network 1 is involved in Amino Acid Metabolism, Endocrine System Development and Function, Molecular Transport. (B) Network 2 is involved in Protein Synthesis, Gene Expression, Cellular Movement. Transcripts are color‐coded, according to expression changes (red, up‐regulation; green, down‐regulation). White indicates predicted molecules computational incorporated into networks based on evidence within the IPA knowledge base. Lines between molecules indicate a direct molecular connection.
Figure 5.The two top gene networks sensitive to resistance wheel running. Ingenuity Pathway Analysis software was used to identify the most significantly modified gene networks from Sed × RWR. (A) Network 1 is involved in Humoral Immune Response, Protein Synthesis, Cellular Movement. (B) Network 2 is involved in Cellular Movement, Immune Cell Trafficking, Humoral Immune Response. Transcripts are color‐coded, according to expression changes (red, up‐regulation; green, down‐regulation). White indicates predicted molecules computational incorporated into networks based on evidence within the IPA knowledge base. Lines between molecules indicate a direct molecular connection.
Figure 6.Confirmation of differentially modified transcripts form microarray analysis. BDNF signalling‐related genes and most up‐ or down‐regulated by WR or RWR were selected for validation via quantitative real‐time PCR. Each column indicates WR (diagonal stripes columns) or RWR (black columns), respectively. For each gene, the expression change is represented as the fold change in WR or RWR relative to Sedentary.